Cargando…
Brachytherapy for Central Serous Chorioretinopathy
Brachytherapy is widely used for the treatment of choroidal melanoma and has recently been explored for the treatment of wet age-related macular degeneration. We propose the use of low dose radiation via episcleral brachytherapy in refractory cases of central serous chorioretinopathy (CSCR). The pat...
Autores principales: | Arora, Supriya, Stea, Baldassarre D., Hamilton, Russell J., Chhablani, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437158/ https://www.ncbi.nlm.nih.gov/pubmed/35793036 http://dx.doi.org/10.1007/s40123-022-00543-6 |
Ejemplares similares
-
Pathomechanisms in central serous chorioretinopathy: A recent update
por: Zarnegar, Arman, et al.
Publicado: (2023) -
Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020) -
Management of chronic central serous chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2018) -
Characteristics of Central Serous Chorioretinopathy without Leakage
por: Parameswarappa, Deepika C., et al.
Publicado: (2021) -
Prevalence of choroidal nevi in patients with central serous chorioretinopathy
por: Maltsev, Dmitrii S., et al.
Publicado: (2023)